Cargando…
A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis
Complement activation in myasthenia gravis (MG) may damage muscle endplate and complement regulatory proteins such as decay-accelerating factor (DAF) or CD55 may be protective. We hypothesize that the increased prevalence of severe extraocular muscle (EOM) dysfunction among African MG subjects repor...
Autores principales: | Heckmann, J M, Uwimpuhwe, H, Ballo, R, Kaur, M, Bajic, V B, Prince, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834500/ https://www.ncbi.nlm.nih.gov/pubmed/19675582 http://dx.doi.org/10.1038/gene.2009.61 |
Ejemplares similares
-
Extraocular Muscle Atrophy in Myasthenia Gravis
por: Pedapati, Radhakrishna, et al.
Publicado: (2022) -
Extraocular Muscle Characteristics Related to Myasthenia Gravis Susceptibility
por: Liu, Rui, et al.
Publicado: (2013) -
Radiological Characteristics of Extraocular Muscles in Myasthenia Gravis Patients with Ocular Manifestations: A Case–Control Study
por: Lueangaram, Sirin, et al.
Publicado: (2021) -
Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report
por: Ma, Ruiqi, et al.
Publicado: (2020) -
Gene expression profiling of orbital muscles in treatment-resistant ophthalmoplegic myasthenia gravis
por: Europa, Tarin A., et al.
Publicado: (2020)